Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 675 participants.

Also called NCT01098981

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 675 participants (enrolled count) (from the registry)
Sponsor
Cerevast Therapeutics, Inc. (from the registry)
Registry
  • NCT NCT01098981
Other papers using this trial's data
  • Combined lysis of thrombus with ultrasound and systemic tissue plasminogen activator for emergent revascularization in acute ischemic stroke (CLOTBUST-ER): design and methodology of a multinational phase 3 trial International journal of stroke : official journal of the International Stroke Society, 2015-10 DOI, PubMed 26120902
  • Safety and efficacy of sonothrombolysis for acute ischaemic stroke: a multicentre, double-blind, phase 3, randomised controlled trial The Lancet. Neurology, 2019-04 DOI, PubMed 30878103

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01098981. Randomized; triple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-04 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial of the Combined Lysis of Thrombus With Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization in Acute Ischemic Stroke
Acronym
CLOTBUST-ER
Condition
Acute Ischemic Stroke
Intervention (Device)
Transcranial ultrasound as an adjunctive therapy to tPA
Intervention (Drug)
Standard of care tPA therapy for acute ischemic stroke
Lead sponsor
Cerevast Therapeutics, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01098981
Content hash
cbdee610c22b0c58ee2777f8cc50420278354cb5bcec68222034649328514690